Research gaps in defining the biological link between HIV risk and hormonal contraception
about
Factors Driving the HIV Epidemic in Southern Africa.Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studiesGonadal function and reproductive health in women with human immunodeficiency virus infection.Progesterone-based intrauterine device use is associated with a thinner apical layer of the human ectocervical epithelium and a lower ZO-1 mRNA expression.Molecular mechanisms linking high dose medroxyprogesterone with HIV-1 risk.Medroxyprogesterone acetate impairs human dendritic cell activation and function.Levels of Genital Tract Defensins and Cytokines Differ between HIV-Uninfected US and African Women.Relationship of Estimated SHIV Acquisition Time Points During the Menstrual Cycle and Thinning of Vaginal Epithelial Layers in Pigtail Macaques.Intravaginal practices among HIV-negative female sex workers along the US-Mexico border and their implications for emerging HIV prevention interventionsEffect of hormonal contraception on the function of plasmacytoid dendritic cells and distribution of immune cell populations in the female reproductive tractMedroxyprogesterone acetate and levonorgestrel increase genital mucosal permeability and enhance susceptibility to genital herpes simplex virus type 2 infection.Effects of the levonorgestrel-releasing intrauterine device on the immune microenvironment of the human cervix and endometrium.Zika virus preferentially replicates in the female reproductive tract after vaginal inoculation of rhesus macaques.Effects of injectable progestogen contraception versus the copper intrauterine device on HIV acquisition: sub-study of a pragmatic randomised controlled trial.Use of injectable hormonal contraception and HSV-2 acquisition in a cohort of female sex workers in Vancouver, Canada.Progesterone-based compounds affect immune responses and susceptibility to infections at diverse mucosal sites.Role of sex hormones and the vaginal microbiome in susceptibility and mucosal immunity to HIV-1 in the female genital tract.Levonorgestrel in contraceptives and multipurpose prevention technologies: does this progestin increase HIV risk or interact with antiretrovirals?A Depot Medroxyprogesterone Acetate Dose That Models Human Use and Its Effect on Vaginal SHIV Acquisition Risk.Analysis of putative mucosal SHIV susceptibility factors during repeated DMPA treatments in pigtail macaques.Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms.Bacterial vaginosis modifies the association between hormonal contraception and HIV acquisition.Is a lower-dose, subcutaneous contraceptive injectable containing depot medroxyprogesterone acetate likely to impact women's risk of HIV?
P2860
Q30387557-61BD6CE2-AAF9-4D23-812A-EC7BD459F19FQ30660068-AF73EC57-248D-4F2F-B206-0A3650ACC047Q34117651-273A5D5E-635E-44B6-AD04-F1B94B3D69BDQ35172396-5401CF88-E673-4847-89EA-5B8506D4F1B8Q35208283-C67C6276-2B3D-4CCC-A298-8DF3851153B8Q35784803-1F551F23-DF2E-456B-8E41-5EA8789D3084Q36068904-095DB4C9-846E-4E5F-8EFC-C3B4D3C08277Q36284595-D6A3372E-54E7-4A62-A7E7-89B2DFB5BDF6Q36828511-F7296EF0-2025-4007-AB6E-58EA336753FBQ36921893-FF7765E0-EC39-4363-BDE8-A027FE5684F4Q37280240-0176A06E-07B3-4349-99D9-9DB23F055639Q37651577-7A94D89E-C34A-4DEA-8370-0D04D707A3FAQ38157367-AEDD677A-07DC-4EDC-9EC9-279D0805AE36Q38851686-38D407DF-C2A0-4A95-9D89-9CE28D655BC1Q39207555-DF1BBEF9-6FE4-45BD-85FF-8D14E20C4265Q39237289-3C9A5666-524C-4805-B56C-72AE281BA1B8Q40047233-E6A222A4-2649-4A59-8BFF-24F09116CC39Q40515915-EE7698EF-A349-4B73-AB58-BDBF1D6B198CQ40632328-897EB29A-FD4B-4B3D-9D60-0479B196216FQ41074827-9CB4FDFF-9CF2-4729-ADA3-EDA7F1CCB328Q47198102-378328E5-10D2-413D-BEF5-1522F94372BEQ47731889-B12A0EB2-3F26-458B-9013-308704739E46Q49838895-0DCE4F36-A8C2-4616-BE5F-B27F3A1BBC12
P2860
Research gaps in defining the biological link between HIV risk and hormonal contraception
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Research gaps in defining the biological link between HIV risk and hormonal contraception
@ast
Research gaps in defining the biological link between HIV risk and hormonal contraception
@en
Research gaps in defining the biological link between HIV risk and hormonal contraception
@nl
type
label
Research gaps in defining the biological link between HIV risk and hormonal contraception
@ast
Research gaps in defining the biological link between HIV risk and hormonal contraception
@en
Research gaps in defining the biological link between HIV risk and hormonal contraception
@nl
prefLabel
Research gaps in defining the biological link between HIV risk and hormonal contraception
@ast
Research gaps in defining the biological link between HIV risk and hormonal contraception
@en
Research gaps in defining the biological link between HIV risk and hormonal contraception
@nl
P2093
P2860
P3181
P356
P1476
Research gaps in defining the biological link between HIV risk and hormonal contraception
@en
P2093
Betsy C. Herold
Kerry Murphy
Susan C. Irvin
P2860
P304
P3181
P356
10.1111/AJI.12209
P407
P577
2014-08-01T00:00:00Z